Inactive Instrument
Company Scibase AB Swiss Exchange
Stocks
SE0007045414
Advanced Medical Equipment & Technology
|
End-of-day quote
Swiss Exchange
|
||
| - SEK | - |
|
| 03-02 | SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion | MT |
| 11-07 | SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan | MT |
Business description: Scibase AB
Executive Committee: Scibase AB
| Manager | Title | Age | Since |
|---|---|---|---|
Pia Renaudin
CEO | Chief Executive Officer | 59 | 01/10/2023 |
Michael Colérus
DFI | Director of Finance/CFO | 64 | 01/01/2014 |
| Chief Tech/Sci/R&D Officer | - | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
Linn Olsen
COO | Chief Operating Officer | 49 | - |
Composition of the Board of Directors: Scibase AB
| Director | Title | Age | Since |
|---|---|---|---|
Diana Ferro
BRD | Director/Board Member | 60 | 16/05/2017 |
Jesper Høiland
CHM | Chairman | 66 | 13/06/2024 |
| Director/Board Member | 68 | - | |
Robert Molander
BRD | Director/Board Member | 61 | - |
Company details: Scibase AB
Medical Diagnostic & Testing Equipment
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.84% | +3.92% | +25.85% | -29.38% | 17.87B | |
| -3.05% | -7.40% | -35.21% | +92.83% | 1.64B | |
| -0.74% | +3.08% | -47.17% | -81.88% | 1.01B | |
| +1.26% | +0.44% | -21.91% | +26.08% | 997M | |
| +0.11% | +0.11% | +59.29% | -6.98% | 780M | |
| -2.29% | -1.45% | -36.88% | -46.39% | 689M | |
| -1.91% | -12.67% | -43.70% | -46.81% | 566M | |
| +3.23% | +2.36% | -40.40% | -35.27% | 457M | |
| +3.19% | +6.69% | +65.58% | +47.72% | 441M | |
| Average | -0.12% | -0.82% | -8.28% | -8.90% | 2.72B | |
| Weighted average by Cap. | -0.78% | +2.23% | +13.97% | -20.00% |
- Stock Market
- Stocks
- Stock
- Stock
- Company Scibase AB
Select your edition
All financial news and data tailored to specific country editions
